Clinical Trial Update: Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety of human mesenchymal stem cells in adults with acute respiratory distress syndrome has been completed and results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Human Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Michael A. Matthay | Conditions: Acute Respiratory Distress Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2017-08-14